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1. Executive!Summary!
The purpose of many ELIXIR Services is to facilitate the open sharing of research data. 
While data and knowledge provided by ELIXIR Services will be accessible to researchers, 
this does not mean that the use of data is unencumbered: restrictions on the use of data 
may arise due to legal (e.g. data protection requirements, copyright protection, or license 
restrictions) or ethical considerations. Especially for ELIXIR Services managing data from 
human research participants that are used in the context of clinical and health research, 
gaining and deserving the trust of patients, study participants and donors concerning the 
proper handling of their data is of utmost importance for research to proceed and 
generate benefits for society. The ELIXIR Ethics Policy provides evidence that an 
adequate level of protection of personal data including sensitive data is in place 
throughout ELIXIR - including across national borders - which increases the acceptance 
of clauses in consent forms concerning data deposition with ELIXIR Services. 
ELIXIR Services are formally defined and must meet specific criteria based on the ELIXIR 
founding documents. Every ELIXIR Service involving personal data must have a 
regulatory framework ensuring that these data are made available for research in a way 
that is compliant with all relevant (e.g. EU-level, national and local or internal) legal and 
ethical requirements. At the same time, ELIXIR is a distributed infrastructure and its 
Nodes are independent organisations. The Node providing an ELIXIR Service is 
responsible for the implementation of the requirements of the ELIXIR Ethics Policy. 
Consequently, the Policy does not prescribe how the specific requirements are met; this is 
up to the Node. 
The Ethics Policy, which is a specific requirement of the ELIXIR founding documents, 
consolidates requirements that are shared across all ELIXIR Members and Services. It 
imposes no additional constraints on the use of data contributed to ELIXIR Services than 
those provided by the Data Controller/Provider or existing legal and ethical requirements. 
ELIXIR Services do not assume the ownership of the data they hold, but provide a 
platform where data controllers/data providers can share their data with the community. 
One of the major achievements made during the development of the ELIXIR Ethics Policy 
is the clear definition of responsibilities with respect to the provision of data underlying 
regulatory requirements into those to be met by the individual researcher or investigator 
or body of researchers or investigators that submits data for access and use in the 
context of an ELIXIR Service (the “data provider”), the ELIXIR Service, and the individual 
researcher or investigator or group of researchers or investigators that accesses and/or 
uses data made available as part of an ELIXIR Service (the “data user”). 
The ELIXIR Ethics Policy is accompanied by a document providing background and 
context for the requirements of the policy (Annex 2). The background document will be 
updated continually and expanded to include more in-depth explanations of the 
requirements included in the policy, where they originate, how they can be implemented, 
and a clarification of how the policy relates to guidance provided by other relevant 
initiatives (such as the GA4GH, among others). 
To facilitate and support implementation in the ELIXIR Nodes, once it has been approved 
by the ELIXIR Board as required by the ELIXIR founding documents, the policy will be 
accompanied by the following supporting materials: 
• operational procedures addressing specific issues in more detail and providing 
recommendations on the implementation of the Policy, which will be developed 
together with Node technical personnel based on specific needs and to address 
relevant use cases (e.g. local EGA instances) and which will address the capacity 
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building requirements of the ELIXIR Consortium Agreement concerning the ethics 
policy 
• a draft, lightweight, compliance check procedure that will tie into procedures 
already under development (Service Delivery Plans, Node reviews, etc.) 
Both activities will be covered by EXCELERATE Subtask 12.2.4: Establish ELIXIR’s 
internal processes for ELSI, for which a milestone is due in project month 24 (August 
2017). 
2. Project!objectives!
This deliverable fulfils one of the Ethics requirements of EXCELERATE. 
With this deliverable, the project has reached or the deliverable has contributed to the 
following objectives: 
 
No.$ Objective$ Yes$ No$
1! Coordinate ELIXIR-EXCELERATE project management with risk 
assessment and quality control to ensure successful and on-time 
completion of the project deliverables 
 x 
2! Conclude the implementation of ELIXIR coordination and 
operational structure and collect defined procedures into ELIXIR 
Handbook of Operations to be available online for all partners 
x  
3! Review the suitability of ELIXIR’s legal framework, as 
recommended by ESFRI, and provide conclusions and options to 
the ELIXIR Board 
 x 
4! Analyse emerging technical data and experiences gained from 
Nodes to update the long-term strategy for the sustainability of 
data management, which will advise future funding strategy and 
the ELIXIR Programme 
 x 
3. Delivery!and!schedule!
The delivery is delayed: !Yes " No 
4. Adjustments!made!
No adjustments were made. 
5. Background!information!
Background information on this WP as originally indicated in the description of action 
(DoA) is included here for reference. 
Work package number  12 Start date or starting event: month 1 
Work package title Excellence in ELIXIR Management and Operations 
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Lead Niklas Blomberg (ELIXIR Director) 
Participant number and person months per participant 
1 – EMBL (120 PM), 6 - NBIC (3.6 PM), 43 - UEDIN (2.4 PM) 
Objectives 
• Coordinate ELIXIR-EXCELERATE project management with risk assessment and 
quality control to ensure successful and on-time completion of the project 
deliverables. (Task 12.1) 
• Conclude the implementation of ELIXIR coordination and operational structure 
and collect defined procedures into ELIXIR Handbook of Operations to be 
available online for all partners. (Task 12.2) 
• Review the suitability of ELIXIR’s legal framework, as recommended by ESFRI, 
and provide conclusions and options to the ELIXIR Board. (Task 12.3) 
• Analyse emerging technical data and experiences gained from Nodes to update 
the long-term strategy for the sustainability of data management, which will advise 
future funding strategy and the ELIXIR Programme. (Task 12.4)  
Description of work and role of partners 
The purpose of this Work Package is to: 
• Run the overall project management function ELIXIR-EXCELERATE; and 
• Deliver value to Member States by completing the ELIXIR Management and 
Operational processes so that ELIXIR Hub and Nodes - operates as a world-class 
distributed infrastructure to its users. 
The WP addresses quality management, risk management, and service sustainability 
and aims to ensure the delivery of long-term, mission-critical services of high quality. It 
also includes activities that ensure ELIXIR takes part in future EU grants as a single 
entity. It delivers the activities that directly addresses the ESFRI recommendations for 
ELIXIR: 1) strengthen the central coordination role of the ELIXIR Hub, 2) evaluate the 
appropriateness of the ELIXIR legal framework, 3) enhance ELIXIR operational 
processes to support the full deployment of the service streams, 4) develop data access 
and ELSI procedures, and 5) develop common procurement and recruitment procedures. 
The two remaining recommendations on industry engagement and expansion of ELIXIR’s 
membership are addressed in WP13. This WP further addresses the long-term 
bottleneck in implementation identified in the Assessment Expert Group review: 
sustainable funding models for critical, core, data resources that bring together national 
and international stakeholders. 
 
Task 12.1: Coordinate ELIXIR-EXCELERATE project management (78PM) (M1-M48) 
Subtask 12.1.1: Day-to-day management, reporting, quality control and risk management 
(40PM) 
The ELIXIR Hub will lead the project management and coordination of ELIXIR-
EXCELERATE. This will, as far as possible, make use of established ELIXIR structures 
and will be complemented by additional resources (where relevant) to ensure appropriate 
project management practice and completion of all reporting requirements. Time in 
regular ELIXIR advisory body meetings will be dedicated to discuss ELIXIR-
EXCELERATE; however, due to the size and complexity of the implementation project, 
additional meetings for Heads of Nodes and other permanent ELIXIR working groups will 
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be required. This task covers all the necessary Project Management, KPI tracking, 
reporting and risk management activities necessary for a large, distributed project and 
embeds these activities in the ELIXIR Hub project management unit. Further, in this task 
the quality control procedures on milestones, deliverables and other project results will be 
established (e.g. internal peer review, HoN review and acceptance for milestones). This 
will ensure that deliverables adhere to some quality principles (such as completeness, 
relevance, uniformity in presentation, etc.), which is important both for internal and 
external communication and reporting to the EC. In order to bring together ELIXIR’s 
users and operators, an international conference: “Landmark in Bioinformatics Services” 
will be organised during the second year of the project. This meeting includes breakout 
sessions and hackathons for ELIXIR users, in addition to keynote talks by external 
experts. The meeting invitation will be extended to related infrastructures with the 
expectation that participants pay for the meeting registration and for their own travel. 
Subtask 12.1.2: Develop and maintain a high-class intranet for project partners, 
committees and governance bodies (38 PM) 
Information flow within the project is ensured through an intranet that will be developed 
and maintained by the ELIXIR Hub. This is a critical task for a large, distributed project 
with multiple partners. It will help the ELIXIR Hub to manage documents, assign tasks, 
report project outcomes, follow up KPIs, manage risks and find people involved in 
ELIXIR. The intranet will be aligned to the ELIXIR website so information can easily flow 
from the private area to the public area. The ELIXIR Hub will also develop and maintain 
system for exposing ELIXIR events, news, vacancies and shared information across the 
ELIXIR Hub and Nodes website. The ELIXIR Hub will adapt the emerging iAnn standard 
to federate this content and provide a solution to facilitate exchange of announcements 
like news and events across ELIXIR Nodes, ELIXIR participants’ institutions as well as 
other relevant organisations in the life sciences domain. Partners: EMBL-ELIXIR 
 
Task 12.2: Conclude the implementation of ELIXIR coordination and operational 
structure (28PM) (M1- M48) 
Subtask 12.2.1: Develop ELIXIR operations framework and processes (23PM) 
In order to ensure pan-ELIXIR coherency in the delivery of high quality and mission-
critical services, ELIXIR has established permanent working groups on technical and 
training services: Technical Coordinators Group (TCG) and Training Coordinator Group 
(TrCG) were formed in 2014. In 2015, upon recruitment of ELIXIR’s Data Coordinator, a 
Data Coordinator Group (DCG) will be established. The coordinator groups constituted 
by Node Technical, Training and Data coordinators and led by the respective ELIXIR 
coordinator, coordinate service objectives and action lines within ELIXIR. In this project 
they have a key role to bring coherence across the Work Packages, in particular the four 
Use Cases (WP6 to 9) and ensure that solutions are made available nationally and to 
other communities. They are also responsible for maintaining a long-term view of their 
respective area. The aim of this task is to drive the technical, data and people 
coordination within ELIXIR by strengthening the ELIXIR permanent working groups 
(DCG, TCG, TrCG). To strengthen the harmonisation of processes across the whole 
infrastructure (the ELIXIR Hub and the Nodes, as well as external interactions), ELIXIR 
procedures, recommendations and guidelines will be collected into a living document: the 
ELIXIR Handbook of Operations. This will be made available through the ELIXIR intranet. 
The handbook will encompass all ELIXIR operations, e.g. the ELSI guidelines, 
communication plan, international strategy, diversity and equal opportunities, common 
procurement and recruitment procedures, and will also link to the Handbook for Nodes 
(delivered by WP10). The handbook is updated annually and final version released at the 
end of this project. According to the ELIXIR governance, any infrastructure-wide policies 
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will need to be decided by the ELIXIR Board and therefore, the Handbook of Operations 
will feed into the development of the next ELIXIR Scientific Programme for 2019-2023, 
which the Board will approve in the spring 2018. Progress on the Handbook development 
will be regularly reported to the ELIXIR Board. 
Subtask 12.2.2: Develop the ELIXIR equal opportunities policy (1PM) 
Gender balance and equal opportunities have already been considered within ELIXIR 
when setting up the ELIXIR governance structure with requirements on e.g. advisory 
boards. In addition, each ELIXIR Node has their own employment policies in place. 
However, there is not yet a developed ELIXIR-wide equal opportunities policy. Within this 
project, the equal opportunity recommendations in access to training and services will be 
reviewed throughout ELIXIR, along with developing the Charter and Code of Access to 
research infrastructures. This task will draw on the diversity work across BMS research 
infrastructures planned within the CORBEL cluster project. In addition, collaborations with 
the emerging NIH BD2K Biomedical Data Science Training Coordination Centre will be 
sought, not only on bioinformatics training and shared infrastructure but also on 
gender/diversity issues. Based on these a good practise recommendation for ELIXIR on 
diversity issues will be completed to be included into the ELIXIR Handbook of 
Operations. 
Subtask 12.2.3: Investigate and recommend options for common procurement across 
Nodes (2PM) 
ESFRI recommends ELIXIR to develop common procurement and recruitment 
procedures. To gain understanding in the processes, we will investigate how commercial 
partners work with data intensive partners in the life science. A feasibility analysis will 
assess options on compute and storage services with ELIXIR datasets and explore joint 
procurement for commercial cloud services, e.g. AWS, Google Cloud, and Azure. This 
analysis will include access for SMEs and will be performed together with WP4 and 
partners from the EMBL-EBI, Finnish and Czech Nodes, who are experts in technical 
services. The ELIXIR Hub will implement the strategy and include it into the ELIXIR 
Handbook of Operations. 
Subtask 12.2.4: Establish ELIXIR’s internal processes for ELSI (1PM) 
Within Europe, BBMRI-ERIC has already established Common Service ELSI 
(http://bbmri-eric.eu/common- services). Although their work is focussing on the 
biobanking community, the Common Service ELSI provides a very useful framework for 
ELIXIR. We are currently developing a Memorandum of Understanding with BBMRI- 
ERIC with the intent of establishing a long-term relationship for ELSI Services that 
maximise infrastructure synergies. The aim of this task is to establish ELIXIR’s internal 
processes for ELSI by bringing together the planned work within CORBEL (see section 
1.3.2) and ELIXIR Nodes’ national ELSI processes and ensure that ELIXIR’s roles, 
policies and responsibilities are clear and transparent – the foundation for effective 
partnership. Once established, the ELSI processes will be included into the ELIXIR 
Handbook of Operations. 
Subtask 12.2.5: Review ELIXIR Node Collaboration Agreements to streamline 
participation on grants (1PM) 
There is a clear need to review and assess the suitability of ELIXIR Nodes’ legal 
structures in the context of EU grant applications, where the intention is for ELIXIR to 
participate in future grants with as fewer numbers of separate beneficiaries as possible. 
ELIXIR-EXCELERATE shows that ELIXIR Nodes - and their various legal forms - are 
very heterogeneous and in many cases don’t yet allow for participation by a single entity. 
Options such as Joint Research Units and Linked Third Parties will be encouraged. 
Partners: EMBL-ELIXIR, NL, UK 
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Task 12.3: Assess the suitability of ELIXIR’s legal framework (14PM) (M18- M36) 
The legal framework of ELIXIR is based on the ELIXIR Consortium Agreement (ECA), 
which has been concluded among the Member States and EMBL and officially entered 
into force on 12 January 2014. The ECA covers ELIXIR’s mission, membership, 
obligations of the Members and the ELIXIR Hub, the governance structure of the ELIXIR 
Hub and relationship to the ELIXIR Nodes. Based on the ECA, EMBL carries out 
activities on behalf of and as mandated by the ELIXIR Consortium that require EMBL’s 
legal personality. ESFRI recommends that under the ELIXIREXCELERATE project, 
ELIXIR would “consider the long term sufficiency of the present legal framework as 
EMBL special project”. Therefore, this task will: 1) Arrange a workshop with ELIXIR 
members to agree on a scope of the legal framework review and develop a request for 
tender document, 2) tender for an external expert to review and compare different legal 
frameworks, and 3) arrange a workshop to conclude recommendations for ELIXIR’s 
future legal framework based on the consultant review. This task will require the ELIXIR 
Board administrative delegates and legal experts from ELIXIR Member States. As the 
Board members are not from partner institutes, their travel costs are budgeted within this 
task. The tender evaluation committee will be appointed by the ELIXIR Board. 
Partners: EMBL-ELIXIR Additional resources required: Procurement (external consultant) 
€60,000  
Task 12.4: Ensuring long-term strategy for the sustainability of data management (6PM) 
(M1-M36) 
The long-term sustainability of Europe’s public data resources is of paramount 
importance. Indeed, ELIXIR is recognized as Europe’s attempt to coordinate, integrate 
and facilitate the long-term sustainability of these critical resources. The aim of this task 
is to evaluate the relevance of the previous work in this area and present an updated, 
forward-looking strategy to feed into the long-term funding strategy and ELIXIR 
Programme for 2019-2023. This task is a direct response to the recommendations of 
both ESFRI and the Assessment Expert Group, and will bring together senior policy 
makers, technical experts and resource owners from ELIXIR Nodes. This task will build 
on other activities within ELIXIR-EXCELERATE. A permanent working group, already 
created within ELIXIR, will work within ELIXIR-EXCELERATE and monitor the emerging 
technical data from WP3 (development of metrics around core resources) and WP5 
(interoperability requirements) and the experiences from WP10 (increased capability from 
Nodes). The WG will consolidate the collected data into a high-level strategy that informs 
the Programme. In addition, institutional good practises will be defined and rolled out via 
the Node Handbook (WP10). The WG members are ELIXIR Board administrative 
delegates and scientific experts from ELIXIR Member States. As the WG members are 
not from partner institutes, their travel costs are budgeted within this task. 
Partners: EMBL-ELIXIR 
!
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1. Introduction+
This document accompanies the ELIXIR Ethics Policy, which is required according to Article 
11 of the ELIXIR Consortium Agreement. The Policy has been developed in consultation 
with or feedback and input from Node technical personnel, Heads of Nodes, Ethics Experts 
on the ELIXIR Scientific Advisory Board, technical staff and external experts. 
The purpose of this document is to support the development, interpretation and application 
of the ELIXIR Ethics Policy by providing background and context. This document does not 
set out any binding requirements over and above the ELIXIR Ethics Policy, which remains 
the authoritative source for resolving any potential issues. 
In order to facilitate its interpretation and application, and to avoid possible confusion, the 
Policy is divided into two sections: one concerning human personal data and one concerning 
non-human and animal data. 
To facilitate and support implementation in the ELIXIR Nodes, once adopted the policy will 
be accompanied by the following: 
 
• Operational procedures addressing specific issues in more detail and providing 
recommendations on the implementation of the Policy, which will be developed 
together with Node technical personnel based on specific needs and to address 
relevant use cases (e.g. local EGA instances) and which will address the capacity 
building requirements of the ELIXIR Consortium Agreement concerning the ethics 
policy 
• A compliance check procedure that will tie into procedures already under 
development (Service Delivery Plans, Node reviews, etc.) 
 
In addition, this background document will be updated continually and expanded to include 
more in-depth explanations of the requirements included in the policy, where they originate, 
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2 
how they can be implemented, and a clarification of how the policy relates to guidance 
provided by other relevant initiatives (such as the GA4GH, among others). 
2. Why+the+policy?+
ELIXIR founding documents stipulate the need for an ELIXIR Ethics policy (see also Figure 
1): 
 
ELIXIR Consortium Agreement 
Article 11 
The ELIXIR Board shall 
[…] establish an ethics policy that is in line with relevant laws and regulations and that 
considers best practices. 
[…] put in place measures to ensure that activities […] shall be in line with this ethics policy. 
[…] implement mechanisms to ensure that ELIXIR Nodes as well as all other collaboration 
partners […] are made aware of their obligation to ensure compliance of all relevant laws 
and regulations (and, where applicable, local ethical guidelines) when handling, storing, or 
processing personally identifiable data resulting from biomedical research. 
 
Node Collaboration Agreements 
10.1.2 ‘Role and tasks of the Head of Node’ 
[...] The tasks of the Head of Node include, but are not limited to the following: 
a. Ensure the compliance of the Node [and all involved national research institutes] with the 
ELIXIR Ethics Policy, national regulations and international best practices; [...] 
e. Provide evidence to the Ethics Advisory Committee in carrying out a review of the ethical 
measures in place at the ELIXIR Node 
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Figure 1 Basis for the Ethics policy as per the ELIXIR legal framework 
3. +
4. Who+are+the+stakeholders?+
Aspects covered by this policy will be relevant to/required by a large variety of stakeholders. 
External stakeholders include: 
• ethics committees and ethics advisory boards (e.g. of large projects) 
• funders, e.g. European Commission (--> see EXCELERATE ethics review) 
• data providers (researchers that want to submit data to ELIXIR Services) 
• data users (researchers that want to use data offered in the context of ELIXIR 
Services) 
• patients/patient groups 
 
ELIXIR-internal stakeholders are: 
• ELIXIR Members/the Board (ELIXIR Consortium Agreement) 
• Nodes: Heads of Nodes, technical staff 
• ELIXIR SAB/Ethics experts 
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5. What+does+the+policy+do?+
The ELIXIR ethics policy provides guidance to ELIXIR Nodes/institutes forming the ELIXIR 
Nodes that provide personally identifiable or Sensitive Data within the distributed ELIXIR 
infrastructure. 
 
The policy: 
• identifies the potential risks concerning legal/ethical aspects of sharing research 
personal data and in particular sensitive data 
• provides first guidance and high level principles concerning how these risks can be 
addressed (this can, and normally will, be refined by internal Node policies that build 
on ELIXIR ”best practices”) 
• describes the roles and responsibilities concerning implementation of ELSI within 
ELIXIR 
6. What+does+the+policy+not+do?+
ELIXIR is a distributed infrastructure with organisationally independent Nodes. The ELIXIR 
Services are delivered by institutes associated with the Nodes in ELIXIR’s Member 
countries, and the legal basis for ELIXIR requires that each Service has its own functioning 
ethics and regulatory oversight in place. In addition, the complexity and diversity of 
regulations around data underlying regulatory requirements - which can vary significantly 
between countries or even individual states within countries, and/or organisations - demands 
that the necessary knowledge and expertise concerning these requirements sits locally with 
the Service provider. 
 
Consequently, the policy does not: 
• dictate the processes at individual institutes that make up an ELIXIR Node 
• replace or supercede local policy and compliance requirements and procedures at 
the ELIXIR Nodes and Node institutes 
• impose additional compliance monitoring processes that interfere with existing 
measures, either at the operational level or in the context of relevant ELIXIR 
procedures (Service Delivery Plans, Node review) 
• impose additional requirements that go beyond existing legal requirements and 
ethics principles 
• require Non-EU member states to adopt EU legislation or directives 
7. What+does+the+policy+cover?+
The ELIXIR Ethics Policy applies solely to ELIXIR Services as defined by the ELIXIR 
founding documents, i.e. Node-funded Services provided in the context of Node 
Collaboration Agreements on the basis of Service Delivery Plans and Commissioned 
Services. It does not apply to any other services provided by the institute constituting or 
affiliated with the ELIXIR Node. 
The specific requirements of the policy apply only to data underlying legal/regulatory 
requirements. It is the Node’s responsibility to ascertain that the ELIXIR Services they 
provide have mechanisms in place that make data submitters and data controllers aware of 
any relevant ethical and legal requirements, in particular requirements for sensitive data. 
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It should be noted that the legal and ethical requirements regarding use and storage of 
sensitive data stem from the applicable laws and regulations and not from the ELIXIR 
founding documents or the ELIXIR Ethics Policy. The role of the Policy is to clarify and 
describe how and by whom the existing legal and ethical requirements are met in the context 
of ELIXIR, and to make this visible to external stakeholders such as funders where required 
(e.g. in the context of grant funding). 
8. What+are+the+critical+ELSI+issues+addressed+in+the+
policy?+
Anonymisation of genetic data. Genetic data can be clearly non-personal data (not rich 
enough to single out an individual), or there can be uncertainty regarding the status of 
anonymity. The distinction between the two cases and the evaluating of the status of 
anonymity of genetic data will be addressed in a best practice document to be developed. 
 
Definition of terms. The policy provides definitions of terms that will be used in the context 
of ELSI and data sharing within ELIXIR (e.g. anonymisation, linked data, data controller)  to 
provide clarity and a basis for detailed policies. 
 
Informed consent. Even broad consent may not be “broad enough” (see Rec. 25aa GDPR). 
Limited consent must be managed.  
 
Ethics Review. The ethics committee landscape is very fragmented in Europe, and there is 
no clear rule concerning where ethics committee reviews are needed. Consequently, it is 
necessary that a competent DAC decides on data use of sensitive data according to local 
law and or applicable ELIXIR best practice. 
9. What+does+the+policy+leave+open?+
In some cases it may be unclear whether data held by a specific Service is sensitive. Such 
“legacy data” may be data that was submitted to the Service longer ago and for which a DTA 
was not concluded as it did not qualify as sensitive data at the time of submission (e.g. due 
to lack of legislation or procedures around informed consent at the time the data was 
generated). There is currently no legal solution to this challenge, so the Policy does not 
address this. 
A possible solution for the Service provider may be to require the user to make a statement 
(e.g. by acknowledging Terms of Use) such as "I understand that this data entered the 
ELIXIR Service without a DTA. I certify that I have duly executed a DTA to obtain this data, 
and will use it consistent with the regulations of my funder, home institution, and current 
scientific best practices." However, any possible approach should always be discussed with 
ethical and legal experts familiar with the specific requirements to be met by the Service. 
10. Who+is+responsible+for+what?+
The Policy must be implemented solely to ELIXIR Services as defined by the ELIXIR 
founding documents, i.e. Node-funded Services provided in the context of Node 
Collaboration Agreements and on the basis of Service Delivery Plans, and Commissioned 
Services provided on the basis of Commissioned Services contracts. It does not apply to any 
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other services or research activities provided by the institute constituting or affiliated with the 
ELIXIR Node. 
 
The policy clearly defines the following roles in the context of data provision via ELIXIR 
Services: 
 
 
Data Provider means the individual researcher or investigator or body of researchers 
or investigators that submits data for access and use in the context of 
an ELIXIR Service 
 
Service Provider  refers to the Node providing an ELIXIR Service 
 
Data User means the individual researcher or investigator or group of 
researchers or investigators that accesses and/or uses data made 
available as part of an ELIXIR Service 
 
 
Each of these has different, clearly defined responsibilities: 
 
General rules (apply to data provider, service provider and data user): 
• Preferability of Processing anonymised Data 
• Processing of Personal Data 
• Non-discrimination of vulnerable groups 
 
Rules to be met by the Service Provider: 
• Data Transfer Agreements 
• Physical Security 
• Controlled Access Data 
• Third-Party-Managed IT Resources 
 
Rules to be met by the Data Provider: 
• Informed Consent 
• Ethics vote and regulatory approvals 
• Incidental Findings 
 
Requirements to be met by the Data User: 
• Adhere to basic ethical principles and conditions of any relevant DTA(s) 
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Figure 2 An ELIXIR Service (e.g. an archive) providing data for research. When implemented the Ethics policy 
only influences the DTAs (e.g. as “Terms of Use” or “Terms of Service) at the “data in” (submission) and “data 
out” (use) ends; the Node retains full responsibility for having a suitable ELSI framework in place for the ELIXIR 
Service in question 
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Figure 3 ELIXIR Service integrating and/or replicating existing data resources, resulting in a new resource with 
different functionality compared to the data sources. As a result, the ELIXIR Service should examine their role 
with respect to the Ethics policy 
11. What+are+the+definitions+of+terms+based+on?+
While a small number of terms have been defined specifically to clarify roles in the provision 
of ELIXIR Services, most definitions of terms are based on several sources, including the 
Global Alliance for Genomics and Health Data Sharing Lexicon and definitions from the 
European General Data Protection Regulation. In several cases, the definitions include 
some level of clarification of the term in the context of providing data for scientific research 
as part of an ELIXIR Services1. 
 
Term Definition References 
Anonymous (or 
Anonymised) Data 
is data that does not relate to an identified or identifiable 
natural person or to data that was personal data at the time 
it was collected but which, using best practices, has been 
rendered anonymous in such a manner that the data 
subject is no longer identifiable 
Refer to Recital 26 GDPR; 
includes considerations on 
implementation 
Consent  means any freely given, specific, informed and 
unambiguous indication of their wishes by which the Data 
GDPR Article 4 
(Definitions) 
                                                
1 http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32016R0679  
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Subject, either by a statement or by a clear affirmative 
action (such as a signed document), signifies agreement to 
Personal Data relating to them being processed 
Data Access 
Committee (DAC) 
means a designated group of individuals who are made 
responsible for reviewing applications and granting 
permission for access to access-controlled datasets. 
Decisions to grant access are made based on whether the 
request conforms to the conditions under which data is 
made available by the Service 
GA4GH Lexicon (includes 
additional clarification on 
the conditions for data 
access) 
Data Protection 
Officer  
means a designated person within an organisation that 
collects Personal Data; he/she acts independently and is 
responsible for making sure that the organisation complies 
with data protection law 
Refer to Article 37, 38, 39 
GDPR 
Data Controller  means the natural or legal person who has the legal and 
actual ability to determine the purposes and means of the 
Processing of Personal Data 
Refer to GDPR Article 4 
(Definitions) 
Data Provider means the individual researcher or investigator or body of 
researchers or investigators that makes data available or 
submits data for access and use in the context of an 
ELIXIR Service 
ELIXIR Ethics Policy 
Data Subject  
 
refers to an identified or identifiable natural person 
(individual) whose data are accessed (e.g. patients, donors 
or study participants) 
Refer to GDPR 
Data Transfer 
Agreement (DTA)  
means an agreement or contract made between a Data 
Provider and a Service Provider (i.e. when data is 
submitted to an ELIXIR Service – “data in”) or a Service 
Provider and a Service user (i.e. when an ELIXIR Service 
makes data available to researchers – “data out”) that 
governs the conditions under which the data is transferred 
and defines the rights of the contracting parties regarding 
future data usage. The DTA can take the form of general 
terms of service or terms of use 
Contractual agreement on 
data provision in the 
context of ELIXIR Services; 
ELIXIR Ethics Policy 
Data User  means the individual researcher or investigator or group of 
researchers or investigators that accesses and/or uses 
data made available as part of an ELIXIR Service 
ELIXIR Ethics Policy 
ELIXIR Service(s)  refers to ELIXIR Services as defined in the Node 
Collaboration Agreements, i.e. Node-funded Services or 
Commissioned Services. 
ELIXIR Node Collaboration 
Agreement 
Ethics Review  means a process, carried out by an Ethics Committee or 
other competent body, resulting in ethical approval for a 
study (or systematic data collection, e.g. biobank) which 
has collected data that will be subsequently made 
available by the Data Provider within an ELIXIR Service 
ELIXIR Ethics Policy 
Genetic Data  means data relating to the genetic characteristics of an 
organism that have been inherited or acquired and which 
may provide unique information about the physiology or 
the health of that organism or individual 
Refer to GDPR Article 4 
(Definitions) 
Incidental Findings  are findings concerning an individual discovered in the 
course of research using data offered in the context of an 
ELIXIR Service that are beyond the original aims of the 
GA4GH Data sharing 
lexicon 
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research 
Personal Data  means any information relating to an identifiable natural 
person (Data Subject); an identifiable natural person is 
someone who can be identified with reasonable efforts, in 
particular by reference to an identifier such as a name, an 
identification number, location data, online identifier or one 
or more factors specific to the physical, physiological, 
genetic, mental, economic, cultural or social identity of that 
person. Genetic Data may be considered non-Personal as 
long as it does not fulfill the criteria of Personal Data 
GDPR Article 4 
(Definitions) 
Processing means any operation that is performed with Personal Data, 
whether or not by automated means, such as collection, 
recording, organization, structuring, storage, adaptation or 
alteration, retrieval, consultation, use, disclosure by 
transmission, dissemination or otherwise making available 
(including use or making available for research purposes), 
alignment or combination, restriction, erasure or 
destruction 
GDPR Article 4 
(Definitions) 
Pseudonymised 
Data (also known as 
‘coded’ or ‘linked’ 
data) 
is data that can only be connected to the Data Subject by 
using additional, separately kept information (a ‘key’) that 
would allow certain authorised individuals (e.g. the clinical 
team who collected the data) to link them back to the 
identifiable Data Subject 
Refer to GDPR Article 4 
(Definitions) 
Sensitive Data  means Personal Data revealing racial or ethnic origin, 
political opinions, religious or philosophical beliefs, or trade 
union membership, genetic data, data concerning health or 
data concerning a natural person's sex life or sexual 
orientation 
GDPR Article 9 (except for 
biometric data as such 
data, where relevant, 
would be covered under 
data concerning health) 
Service Provider  refers to the Node providing an ELIXIR Service ELIXIR Ethics policy 
Supervisory 
Authority  
means an independent public authority established in order 
to supervise and decide critical issues in a specific area 
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ELIXIR ETHICS POLICY 
 
 
 
 
 
 
 
 
 
 
 
Author of the paper 
ELIXIR Director 
Purpose of the paper 
To present the proposed ELIXIR Ethics Policy to the ELIXIR Board 
 
Action required 
 
The Board is asked to review and approve the policy presented 
 
Voting requirements 
 
Decision by simple majority is required by application of ECA Art. 6.2.4.bb (TBC) 
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ELIXIR ETHICS POLICY  
1. Considerations 
i. The ELIXIR founding documents place special emphasis on the development of 
an ELIXIR Ethics Policy in order to support the sharing of data underlying 
specific regulatory requirements, especially Personal Data including Sensitive 
Data. The Policy is established and approved by the ELIXIR Board as set forth 
in Art. 11 of the ELIXIR Consortium Agreement and provides the basis for the 
implementation of the requirements arising from the Node Collaboration 
Agreements. 
ii. Some ELIXIR Services manage data from human research participants and are 
used in the context of clinical and health research. Gaining and deserving the 
trust of patients, study participants and donors concerning the proper handling 
of their data is of utmost importance for research to proceed and generate 
benefits for society. 
iii. The purpose of this Policy is to support the process of making scientific data 
available in the context of ELIXIR in an ethically and legally sound manner by 
consolidating requirements that are shared across all ELIXIR Members and 
Services, including those arising from the ELIXIR founding documents. This 
Policy imposes no additional constraints on the use of data contributed to 
ELIXIR Services than those provided by the Data Controller/Provider or existing 
legal and ethical requirements. 
iv. ELIXIR recognises that while data and knowledge provided by ELIXIR Services 
will be accessible this does not mean that the use of data is unencumbered: 
restrictions on the use of data may arise due to legal (e.g. data protection 
requirements, copyright protection, or license restrictions) or ethical 
considerations. Copyright, intellectual property or license considerations are not 
covered in this policy. 
v. ELIXIR recognises that the purpose of many ELIXIR Services is to facilitate the 
open sharing of research data; they do not assume the ownership of the data 
but provide a platform where Data Controllers/Providers can share their data 
with the community.   
vi. Every ELIXIR Service (i.e. Node-funded Services included in Service Delivery 
Plans and Commissioned Services - either Implementation Studies or 
Infrastructure Services) involving Personal Data including Sensitive Data must 
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have a regulatory framework ensuring that these data are made available for 
research in a way that is compliant with all relevant (e.g. EU-level, national and 
local or internal) legal and ethical requirements. 
vii. The ELIXIR Nodes are responsible for the implementation of the requirements 
of the Policy with respect to the provision of ELIXIR Services. The Policy does 
not prescribe how the specific requirements are met; this is up to the Node. 
viii. ELIXIR Services make data available for research on the basis of scientific best 
practice and conventions and using state of the art technology. Via 
mechanisms for knowledge exchange and capacity building across its Nodes, 
ELIXIR ensures excellence in the delivery of ELIXIR Services. 
ix. The ELIXIR Ethics Policy provides evidence that an adequate level of 
protection of Personal Data including Sensitive Data is in place throughout 
ELIXIR - including across national borders - which increases the acceptance of 
clauses in Consent forms concerning data deposition with ELIXIR Services. 
This is especially relevant with respect to gaining approval of ethics committees 
or other competent oversight bodies, which are established on the basis of a 
variety of laws and regulations and in very different ways both with respect to 
their composition as well as the scope and granularity of ethical reviews. Since 
research projects are reviewed on the basis of relevant legal and ethical 
standards, many ethics committees are reluctant to approve data sharing 
beyond borders when there is no cross-border standard of data sharing policies 
in place. This Policy provides that standard. 
x. This Policy is intended to provide the required basis to satisfy the ethics 
requirements of funders, such as for example those of the European 
Commission’s Horizon 2020 framework. 
xi. ELIXIR Services participate in a multitude of research projects in both national 
and international settings that are governed by project-specific policies and 
codes. Such policies may impose additional requirements on ELIXIR Services 
that go beyond the scope of this policy. 
2. Scope 
This Policy applies to ELIXIR Services that make data underlying specific regulatory 
requirements available. 
 
The Policy applies solely to ELIXIR Services as defined by the ELIXIR founding 
documents1, i.e. Node-funded Services provided in the context of Node Collaboration 
Agreements and on the basis of Service Delivery Plans, and Commissioned Services 
provided on the basis of Commissioned Services contracts. It does not apply to any 
                                                
1!see!ELIXIR!founding!documents:!ELIXIR!Consortium!Agreement!and!Node!Collaboration!Agreement 
ANNEX 2 to EXCELERATE Deliverable 12.1: ELIXIR Ethics policy 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
ELIXIR'Ethics'Policy|'ELIXIR'/'2016'/'x'''''''''''' ' ' ''''''''''''''''''4/13'
Meeting'date:'21!22'November'2016'
'
This%document%was%last%edited%on:%22%August%2016 
 
other services or research activities provided by the institute(s) constituting or affiliated 
with the ELIXIR Node. 
 
The vast majority of data made available for research via ELIXIR Services is freely 
available and open for use by the scientific community. For data subject to regulatory 
requirements, this Policy provides the framework to ensure that provision of data 
through ELIXIR Services is consistent with the relevant laws and regulations, good 
scientific practice and ethical principles as they are agreed within the research 
community. 
 
The Policy does not cover the handling of data that are not processed within, or made 
available for research by, an ELIXIR Service. 
3. Legal Basis 
As set forth in Art 11. of the ELIXIR Consortium Agreement, the ELIXIR Board shall 
establish an Ethics Policy that is in line with relevant laws and regulations and that 
considers best practices. 
 
This Policy is designed to be inter alia compliant with national laws and relevant 
international regulations: 
● Universal Declaration of Human Rights, 10 December 1948 
● Article 8 of the European Convention on Human Rights 
● Council of Europe Convention for the Protection of Individuals with Regard to 
Automatic Processing of Personal Data 1981 (convention 108) 
● Charter of Fundamental Rights of the European Union 2010/C 83/0215 
● Directive 95/46/EC of the European Parliament of 24 October 1995 on the 
protection of individuals with regard to the processing of Personal Data and on 
the free movement of such data 
● Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 
April 2016 on the protection of natural persons with regard to the processing of 
personal data and on the free movement of such data, and repealing Directive 
95/46/EC (General Data Protection Regulation) 
● Nagoya Protocol on access to genetic resources and the fair and equitable 
sharing of benefits arising from their utilization to the convention on biological 
diversity, 29 October 2010  
● European Convention for the Protection of Vertebrate Animals used for 
Experimental and Other Scientific Purposes, Strasbourg, 18.III.1986 
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4. Basic Ethical Principles 
4.1 Human dignity and autonomy 
The principle of human autonomy and self-determination is acknowledged by 
respecting the preferences of the Data Subject as expressed in their statement of 
Consent and by exercising diligence in the management of Personal Data in order to 
ensure the security of such data. Persons who are not in a position to make decisions 
freely and independently (people incapable of giving Consent) are covered by 
provisions of special protection. 
4.2 Non-discrimination 
Protection against discrimination requires equal treatment and respect for all persons 
whose data are used in research. The interests and needs of every person must be 
respected without bias; every person must be protected from harm and treated with 
care impartially. 
 
Stigmatisation of subsets of the population via certain data analyses is to be avoided 
even if it may be induced unintentionally. 
4.3 Good scientific practice 
Good scientific practice includes scientific honesty and diligence (professionalism, 
forthrightness, transparency) in the stewardship of data, samples, and research results. 
It is subverted by scientific dishonesty (deception, fraud, illegitimate use of knowledge 
from other sources). 
4.4 Public benefit 
Biomedical research serves the greater well-being of all humankind. Its benefit to 
society consists in achieving greater insight into the foundations of biology as well as in 
integrating its findings into clinical care. For the sake of realising societal benefit, it is 
necessary to ensure the broadest participation, which includes the general public, in 
sharing the benefits of scientific advancement. 
5. Definition of terms 
The definitions below shall be considered only for the purpose of this Policy. Some 
definitions from the General Data Protection Regulation have been adapted for the 
purpose of this Policy. 
 
Anonymous (or Anonymised) Data is data that does not relate to an identified or 
identifiable natural person or to data that was personal data at the time it was collected 
but which, using best practices, has been rendered anonymous in such a manner that 
the data subject is no longer identifiable. 
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Consent means any freely given, specific, informed and unambiguous indication of 
their wishes by which the Data Subject, either by a statement or by a clear affirmative 
action (such as a signed document), signifies agreement to Personal Data relating to 
them being processed. 
 
Data Access Committee (DAC) means a designated group of individuals who are made 
responsible for reviewing applications and granting permission for access to access-
controlled datasets. Decisions to grant access are made based on whether the request 
conforms to the conditions under which data is made available by the Service. 
 
Data Protection Officer means a designated person within an organisation that collects 
Personal Data; he/she acts independently and is responsible for making sure that the 
organisation complies with data protection law. 
 
Data Controller means the natural or legal person who has the legal and actual ability 
to determine the purposes and means of the Processing of Personal Data. 
 
Data Provider means the individual researcher or investigator or body of researchers or 
investigators that makes data available or submits data for access and use in the 
context of an ELIXIR Service. 
 
Data Subject refers to an identified or identifiable natural person (individual) whose 
data are accessed (e.g. patients, donors or study participants). 
 
Data Transfer Agreement (DTA) means an agreement or contract made between a 
Data Provider and a Service Provider (i.e. when data is submitted to an ELIXIR Service 
– “data in”) or a Service Provider and a Service user (i.e. when an ELIXIR Service 
makes data available to researchers – “data out”) that governs the conditions under 
which the data is transferred and defines the rights of the contracting parties regarding 
future data usage. The DTA can take the form of general terms of service or terms of 
use. 
 
Data User means the individual researcher or investigator or group of researchers or 
investigators that accesses and/or uses data made available as part of an ELIXIR 
Service. 
 
ELIXIR Service(s) refers to ELIXIR Services as defined in the Node Collaboration 
Agreements, i.e. Node-funded Services or Commissioned Services. 
 
Ethics Review means a process, carried out by an Ethics Committee or other 
competent body, resulting in ethical approval for a study (or systematic data collection, 
e.g. biobank) which has collected data that will be subsequently made available by the 
Data Provider within an ELIXIR Service. 
 
Genetic Data means data relating to the genetic characteristics of an organism that 
have been inherited or acquired and which may provide unique information about the 
physiology or the health of that organism or individual. 
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Incidental Findings are findings concerning an individual discovered in the course of 
research using data offered in the context of an ELIXIR Service that are beyond the 
original aims of the research. 
 
Personal Data means any information relating to an identifiable natural person (Data 
Subject); an identifiable natural person is someone who can be identified with 
reasonable efforts, in particular by reference to an identifier such as a name, an 
identification number, location data, online identifier or one or more factors specific to 
the physical, physiological, genetic, mental, economic, cultural or social identity of that 
person. Genetic Data may be considered non-Personal as long as it does not fulfill the 
criteria of Personal Data. 
Processing means any operation that is performed with Personal Data, whether or not 
by automated means, such as collection, recording, organization, structuring, storage, 
adaptation or alteration, retrieval, consultation, use, disclosure by transmission, 
dissemination or otherwise making available (including use or making available for 
research purposes), alignment or combination, restriction, erasure or destruction. 
 
Pseudonymised Data (also known as ‘coded’ or ‘linked’ data) is data that can only be 
connected to the Data Subject by using additional, separately kept information (a ‘key’) 
that would allow certain authorised individuals (e.g. the clinical team who collected the 
data) to link them back to the identifiable Data Subject. 
 
Sensitive Data means Personal Data revealing racial or ethnic origin, political opinions, 
religious or philosophical beliefs, or trade union membership, genetic data, data 
concerning health or data concerning a natural person's sex life or sexual orientation. 
 
Service Provider refers to the Node providing an ELIXIR Service. 
 
Supervisory Authority means an independent public authority established in order to 
supervise and decide critical issues in a specific area. 
6. Human Personal Data 
General Requirements 
6.1 Preferability of Processing anonymised data 
Anonymous or Anonymised Data can be Processed without data protection 
constraints. Wherever possible with regard to the purpose of the ELIXIR Service, data 
Processing shall only take place with Anonymous or Anonymised Data. 
 
Whether Pseudonymised Data can be considered Anonymous Data for everybody who 
has no access to the key (linkage code, cipher), or who has no means to trace back 
the Data Subject via additional information (concept of relative anonymisation), is not 
unambiguously clarified on the EU level and depends on the relevant jurisdiction. An 
Ethics Review should be conducted and/or the Data Protection Officer or Supervisory 
Authority should be consulted in cases of doubt. 
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Anonymisation should be achieved using state of the art techniques that are used in 
practice. It is sufficient that the data is de facto anonymised, i.e. individuals cannot be 
re-identified by the use of reasonable means. When assessing re-identification risks all 
factors have to be considered, including for example context knowledge that is 
available to the data users, access control systems that ensure data is only used for 
biomedical research purposes in order to reduce available context knowledge, 
sensitivity of the data, etc. 
6.2 Processing of Personal Data 
Personal Data can only be processed if 
● the Data Subject has given their Consent for the purpose of the Processing and 
according to para. 3, or 
● the Processing is compliant with an applicable legal authorization, 
 
and the use for biomedical research has been reviewed following an established Ethics 
Review process according to para. 9. 
 
The Data Controller overseeing the provision of Personal Data in the context of an 
ELIXIR Service has to ensure that the intended Processing is lawful (e.g. through a 
Data Access Committee). Where an ELIXIR Service makes patient data or data from 
donors of biomaterial or Genetic Data available, prime consideration should be given 
as to whether the Data Provider has given sufficient evidence (e.g. in the context of a 
DTA) that the available Consent allows this. 
 
Novel ways of combining data or datasets in the context of ELIXIR can proceed as long 
as the data is Anonymised or Pseudonymised and approval has been granted following 
an Ethics Review, or by a Supervisory Authority or equivalent where required. Where 
there is doubt that Consent provisions adequately cover the combination of datasets, 
an Ethics Review should clarify or the opinion of a Supervisory Authority or equivalent 
should be sought as to whether additional participant Consent is required. This should 
normally happen within the context of the research project seeking to combine the 
datasets using the ELIXIR infrastructure and attested through DTAs. 
 
No further Consent will need to be sought where pre-collected Consent by the Data 
Subject adequately covers the provision of data in the context of the ELIXIR Service. 
 
Where adequate Consent has not been obtained, or where there is doubt, the Data 
Provider should seek approval via an Ethics Review and, where relevant legal (e.g. 
national) requirements dictate, from a relevant regulatory body or Supervisory 
Authority, before the data can be deposited. An example for this may be pre-collected 
data where Consent or approval was not broad enough to include the provision of the 
data in the context of an ELIXIR Service. Re-Consent might not be necessary if 
approval is granted following an Ethics Review or by a relevant Supervisory Authority 
confirming that the benefit of providing the data in the context of ELIXIR outweighs any 
risk to the Data Subject, and where local, regional or national or other relevant 
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regulations allow this decision to be made by relevant Supervisory Authorities or via 
Ethics Reviews. 
 
Even with Consent or a legal basis for Processing Personal Data, the principle of data 
minimisation has to be taken into account: Data should be de-identified if the research 
objectives can still be achieved with a de-identified data set. 
6.3 Non-discrimination of vulnerable groups 
Certain data analyses may confer non-intentional stigmatisation of subsets of the 
population involved. Consequently, any data analysis using ELIXIR Services that may 
have the potential to cause stigmatisation must be carefully considered and discussed 
in the context of an Ethics Review in order to obtain further guidance prior to the 
analyses being undertaken. The responsibility to ensure appropriate Consent and 
approval based on an Ethics Review or from a national authority lies exclusively with 
the Data Provider and must be in place before data is made available in the context of 
ELIXIR Services. 
Requirements to be met by the Service Provider 
6.4 Data Transfer Agreements (DTAs) 
Any Transfer of Personal Data should be based on formal agreements such as DTAs. 
The Service Provider must conclude two types of DTAs: one with the Data Provider 
before data is submitted to the ELIXIR Service and one with the Data User before data 
is made available for research. These DTAs can be implemented as Terms of Use or 
Terms of Service. 
 
At the point of data submission (“data in”) and where applicable, any such agreement 
must reflect that the Data Provider is submitting the data to the Service only after 
having secured the necessary Informed Consent by the Data Subject and/or taking into 
account any other limitations, such as for example deriving from ethics reviews or 
relevant law, or the requirement to feedback Incidental Findings. It is advisable that the 
DTA also include a provision for the Data Provider to inform the Service Provider 
should the need to remove Personal Data arise for example when Consent is 
withdrawn. 
 
At the point of data use (“data out”), in the case of data requiring Consent by the Data 
Subject, it is advisable that the DTA between the Service Provider and the Data User 
exclude any further data transfer from the side of the Data User or, where such transfer 
is intended, include a requirement for the Data User to document any such data 
transfer in case Consent for Personal Data is withdrawn in order to be able to comply 
commensurately with a revocation of Consent. The Service Provider might also 
consider referring to the ELIXIR Ethics Policy in this DTA. 
 
For the avoidance of doubt, the responsibility for meeting any applicable requirements 
around Consent, Ethics Reviews and Incidental Findings remains with the Data 
Provider. 
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6.5 Physical Security 
Adequate measures based on current and continuously updated best practice, which 
may include formal certification, should be implemented to guarantee the physical 
security of data during the Processing within the context of an ELIXIR Service. 
6.6 Controlled Access to Data 
Controlled access to Personal Data should be implemented unless the available 
consent or other considerations allow fully unrestricted open access.  
 
The Service Provider is responsible for ensuring levels of data security appropriate for 
the type of data held. 
 
The access procedure should be transparent to ensure fair access. The principles 
governing the use of data after access has been granted should be outlined in a DTA 
(see para 4).   
 
Controlled access to data is provided on the basis of an appropriate data security plan 
that is based on current and continuously updated best practice and which may include 
formal certification.  
 
Additional restrictions may be imposed by the ELIXIR Service home organisation's IT 
requirements and policies, e.g. regarding server, network, and application security. 
6.7 Third Party-Managed IT resources 
Increasingly, IT services are moving from local servers and hardware managed by the 
organisation's own staff to systems owned and managed by third party providers. 
Transfer and storage of controlled access data on third party systems require 
additional considerations. 
 
Thus, it is advisable that institutions validate that they are partnering with a reputable 
third party provider and develop appropriate security plans and service agreements 
before data is migrated to third party providers. Migration of person-related data to 
servers located in other countries also require consideration of relevant data protection 
regulation (e.g. in the case of non-EU cloud services, it should be ensured that it is 
legally allowed, for example because the foreign country has been declared a “safe” 
country by the EU Commission or the Consent of the Data Subject explicitly allows the 
transfer). 
Requirements to be met by the Data Provider 
6.8 Informed Consent 
a) Requirements 
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Drafting Consent forms and obtaining and managing Consent for data collections is 
entirely the responsibility of the researcher collecting the data deposited in ELIXIR 
Services (who may or may not be the same as the Data Provider). The responsibility to 
ensure that appropriate Consent and/or Ethics Committee or other Supervisory 
Authority approval is in place before data is deposited and/or made available in the 
context of the ELIXIR Service lies exclusively with the Data Provider. The Data 
Provider remains responsible for managing the Consent. 
 
Consent must be documented. It is advisable that the Service Provider ensures that 
the Data Provider’s responsibility for obtaining Consent is clearly stated in the DTA 
between the Data Provider and the Service Provider. 
 
Consent forms should be drafted to adequately cover the use in the context of an 
ELIXIR Service concerning: 
● access to and linkage of data that is stored in an electronic database 
● sharing of data with other researchers within and outside of the country 
● any decisions made regarding the management and communication of findings 
of individual clinical significance (Incidental Findings), including any obligations 
data consumers may have to communicate findings, and any pre-set time-limits 
for the feeding back of results 
● the possibility of the data being used in a commercial context. 
 
b) Withdrawal of Consent 
 
Personal Data are to be destroyed upon withdrawal of Consent except in cases where 
the relevant law allows or requires data retention. The Data Provider is responsible for 
informing the Service Provider should any such need arise, and it is advisable that this 
responsibility is clearly stated in the DTA between the Data Provider and the Service 
Provider. 
6.9 Ethics Review and regulatory approvals 
The Data Provider must ensure that an Ethics Review as required by all relevant law 
and internationally agreed standards has been completed. An Ethics Review is always 
required where the Consent form indicates that Consent has been given on the 
condition that such review is conducted before data is processed (i.e. used for a given 
research project). The ethicsreview must cover the secondary use of data e.g. through 
submission and managed access through an ELIXIR Service. 
 
In cases where the DAC considers an Ethics Review necessary but where this is not 
already available, it can build an ad hoc ethics committee or equivalent body to 
conduct the appropriate review. 
 
Data protection authority approval must be obtained if required by relevant law. 
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6.10 Incidental Findings 
Where there is a requirement to return Incidental Findings to Data Subjects, the 
responsibility to ensure that appropriate Consent and mechanisms of feedback, which 
must have been Consented to by the Data Subject and agreed in an Ethics Review or 
by a Supervisory Authority, lies exclusively with the Data Provider and must be in place 
before data is deposited and/or made available in the context of ELIXIR Services. 
Requirements to be met by the Data User 
Besides meeting the requirements as laid out in the DTA between the Service Provider 
and Data User (which can take the form of Terms of Use or Terms of Service), the 
Data User must adhere to the Basic Principles described in this policy concerning 
Human Dignity and Authority, Non-Discrimination, Good Scientific Practice and Public 
Benefit. 
7. Non-Human Data including Animal Data 
7.1 Rules 
Where animal data is made available for research via an ELIXIR Service, the Data 
Provider must ensure that relevant guidelines and laws for the animals' welfare and 
care during collection of the data were followed. 
 
Where non-human genome data is made available, use and provision in the context of 
an ELIXIR Service must be compliant with the relevant national implementation of the 
Nagoya Protocol. 
 
As described under section F. Human Personal Data (para 4), these rules can be 
implemented in a Data Transfer Agreement, for example as Terms of Use or Terms of 
Service, taking the different perspectives described above (Data Provider, Service 
Provider, Data User) into account. 
8. Approval, implementation, monitoring and 
development of this Policy 
8.1 Approval 
The responsibility for the approval of the ELIXIR Ethics Policy lies with the ELIXIR 
Board. 
 
The ELIXIR Director is responsible for ensuring that the Policy is routinely reviewed by 
the ELIXIR Scientific Advisory Board in order to improve it and to keep it continuously 
up-to-date with new advances in basic research and bioinformatics as well as 
developments concerning ethical and legal requirements. Feedback from the Heads of 
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Nodes Committee and via the Collaboration Oversight Groups for individual Nodes will 
also be sought regularly. 
8.2 Implementation and compliance 
As per Art. 10.1.2g of the Node Collaboration Agreements, the ELIXIR Heads of Nodes 
are responsible for ensuring compliance with this Policy for the ELIXIR Services 
offered by the respective Node.  
 
For the sake of clarity, and as indicated in Art. 14 of the Node Collaboration 
Agreement, each ELIXIR Node is responsible to implement its own policies in order to 
ensure that the Services provided within ELIXIR comply with the ELIXIR Ethics Policy 
and national rules and regulations as well as international standards of best practice. 
8.3 Information 
As per Art. 14 of the Node Collaboration Agreement, the ELIXIR Hub shall remind the 
ELIXIR Node of its obligation to ensure compliance of all relevant laws and regulations 
(and, where applicable, local ethical guidelines) when handling, storing, or processing 
personally identifiable data resulting from biomedical research. 
8.4 Monitoring 
The Collaboration Oversight Group, which is established by the Parties to the Node 
Collaboration Agreement and comprises the ELIXIR Director, the Head of Node and 
other individuals appointed by them, shall monitor the compliance of ELIXIR Services 
provided by the Node in question2. 
 
In collaboration with the ELIXIR Scientific Advisory Board and supported by the Node 
in question, data concerning ELIXIR Service compliance with the ELIXIR Ethics Policy 
will be gathered by the Hub and submitted to the ELIXIR Scientific Advisory Board in 
the context of regular ELIXIR Service reviews.  
 
In accordance with Art. 11.2 of the Node Collaboration Agreement, upon 
recommendation of the ELIXIR Scientific Advisory Board (including Ethics Experts and 
replacing the Ethics Advisory Committee as per the ELIXIR Board decision 
DD/MM/YYYY), the ELIXIR Board shall decide whether it wishes to renew or terminate 
(in whole or in part) the Agreement with the ELIXIR Node. 
 
 
 
This Policy has been adopted by the ELIXIR Board on November, .. 2016. 
 
 
                                                
2 It should be noted that the Collaboration Oversight Group works as a flexible structure to 
facilitate communication, but the rights and obligations of the ELIXIR Director and the Head of 
Node remain unaffected as stated in Art. 10.2.2 of the ELIXIR Collaboration Agreement. 
